Enas Elbahnasawy
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Role not yet determined Is this you? Add your title
Also affiliated: University of Arkansas Medical Center (2026); Menoufia University (2025)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Enas Elbahnasawy's research has focused on investigating the gastrointestinal effects of sevelamer, a phosphate binder commonly used in patients with chronic kidney failure. Their work includes a case series and literature review examining mucosal cell injury caused by sevelamer crystals, with a response to a letter to the editor on this topic also published. Additionally, Elbahnasawy has contributed to medical case reports, including one detailing acquired hemophilia A associated with amlodipine use in a hypertensive patient. Their scholarly output includes three publications with a total of four citations and an h-index of 1. Elbahnasawy is a recently active researcher.
Metrics
- h-index: 1
- Publications: 3
- Citations: 5
Selected Publications
-
Response to Letter to the Editor “Gastrointestinal Mucosal Cell Injury Caused by Sevelamer” (2026)
Collaboration Network
Top Collaborators
- Response to Letter to the Editor “Gastrointestinal Mucosal Cell Injury Caused by Sevelamer”
- Response to Letter to the Editor “Gastrointestinal Mucosal Cell Injury Caused by Sevelamer”
- Response to Letter to the Editor “Gastrointestinal Mucosal Cell Injury Caused by Sevelamer”
- Response to Letter to the Editor “Gastrointestinal Mucosal Cell Injury Caused by Sevelamer”
- Response to Letter to the Editor “Gastrointestinal Mucosal Cell Injury Caused by Sevelamer”
Similar Researchers
Based on overlapping research topics